Lubov Grigoryeva

Lubov Grigoryeva, PhD is currently a Senior Scientist at Capsida Biotherapeutics, leading the Immunogenicity team. Prior to this role, Lubov held positions at Northwestern University, Feinberg School of Medicine, Massachusetts General Hospital, Université de Montréal, McGill University, and Penn State University. Lubov's educational background includes a PhD in Microbiology and Immunology, a Master of Science in Clinical Investigation, and a Bachelor of Science in Biology. Throughout their career, Lubov has conducted research in various areas such as immune cells in the male reproductive system, lysosomal storage diseases, brain and eye morphology in fish species, cellular components in bone, and genes/proteins involved in lung cancer development.